nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—esophageal cancer	0.49	1	CbGaD
Propafenone—CYP2C9—Capecitabine—esophageal cancer	0.0407	0.433	CbGbCtD
Propafenone—CYP2C9—Cisplatin—esophageal cancer	0.0205	0.218	CbGbCtD
Propafenone—ABCB1—Cisplatin—esophageal cancer	0.0199	0.212	CbGbCtD
Propafenone—ABCB1—Methotrexate—esophageal cancer	0.0129	0.137	CbGbCtD
Propafenone—Carvedilol—HIF1A—esophageal cancer	0.00274	0.339	CrCbGaD
Propafenone—Oxaprozin—PTGS1—esophageal cancer	0.00105	0.13	CrCbGaD
Propafenone—Salsalate—PTGS1—esophageal cancer	0.00105	0.13	CrCbGaD
Propafenone—Mirabegron—ABCB1—esophageal cancer	0.000704	0.0872	CrCbGaD
Propafenone—Coma—Methotrexate—esophageal cancer	0.000612	0.00239	CcSEcCtD
Propafenone—Blood creatinine increased—Capecitabine—esophageal cancer	0.000612	0.00239	CcSEcCtD
Propafenone—Dehydration—Capecitabine—esophageal cancer	0.000608	0.00237	CcSEcCtD
Propafenone—Ecchymosis—Methotrexate—esophageal cancer	0.000606	0.00237	CcSEcCtD
Propafenone—Mouth ulceration—Methotrexate—esophageal cancer	0.000606	0.00237	CcSEcCtD
Propafenone—Urinary tract disorder—Cisplatin—esophageal cancer	0.000606	0.00236	CcSEcCtD
Propafenone—Liver function test abnormal—Capecitabine—esophageal cancer	0.000603	0.00236	CcSEcCtD
Propafenone—Connective tissue disorder—Cisplatin—esophageal cancer	0.000603	0.00235	CcSEcCtD
Propafenone—Urethral disorder—Cisplatin—esophageal cancer	0.000601	0.00235	CcSEcCtD
Propafenone—Dry skin—Capecitabine—esophageal cancer	0.000599	0.00234	CcSEcCtD
Propafenone—Salsalate—PTGS2—esophageal cancer	0.000598	0.0741	CrCbGaD
Propafenone—Oxaprozin—PTGS2—esophageal cancer	0.000598	0.0741	CrCbGaD
Propafenone—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000597	0.00233	CcSEcCtD
Propafenone—Hypokalaemia—Capecitabine—esophageal cancer	0.000595	0.00232	CcSEcCtD
Propafenone—Visual impairment—Cisplatin—esophageal cancer	0.000591	0.00231	CcSEcCtD
Propafenone—Breast disorder—Capecitabine—esophageal cancer	0.00059	0.00231	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000588	0.0023	CcSEcCtD
Propafenone—Carvedilol—PTGS1—esophageal cancer	0.000582	0.0721	CrCbGaD
Propafenone—Gastritis—Capecitabine—esophageal cancer	0.000578	0.00226	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000576	0.00225	CcSEcCtD
Propafenone—Muscular weakness—Capecitabine—esophageal cancer	0.000576	0.00225	CcSEcCtD
Propafenone—Eye disorder—Cisplatin—esophageal cancer	0.000573	0.00224	CcSEcCtD
Propafenone—Tinnitus—Cisplatin—esophageal cancer	0.000572	0.00223	CcSEcCtD
Propafenone—Lymphadenopathy—Methotrexate—esophageal cancer	0.00057	0.00223	CcSEcCtD
Propafenone—Cardiac disorder—Cisplatin—esophageal cancer	0.000569	0.00222	CcSEcCtD
Propafenone—Flushing—Cisplatin—esophageal cancer	0.000569	0.00222	CcSEcCtD
Propafenone—Abdominal distension—Capecitabine—esophageal cancer	0.000569	0.00222	CcSEcCtD
Propafenone—Dysphagia—Capecitabine—esophageal cancer	0.000565	0.0022	CcSEcCtD
Propafenone—Influenza—Capecitabine—esophageal cancer	0.000565	0.0022	CcSEcCtD
Propafenone—Diabetes mellitus—Methotrexate—esophageal cancer	0.000559	0.00218	CcSEcCtD
Propafenone—Polyuria—Methotrexate—esophageal cancer	0.000554	0.00216	CcSEcCtD
Propafenone—Immune system disorder—Cisplatin—esophageal cancer	0.000554	0.00216	CcSEcCtD
Propafenone—Mediastinal disorder—Cisplatin—esophageal cancer	0.000553	0.00216	CcSEcCtD
Propafenone—Angina pectoris—Capecitabine—esophageal cancer	0.00055	0.00215	CcSEcCtD
Propafenone—Sweating increased—Capecitabine—esophageal cancer	0.00055	0.00215	CcSEcCtD
Propafenone—Arrhythmia—Cisplatin—esophageal cancer	0.000548	0.00214	CcSEcCtD
Propafenone—Alopecia—Cisplatin—esophageal cancer	0.000542	0.00212	CcSEcCtD
Propafenone—Erythema—Cisplatin—esophageal cancer	0.000534	0.00208	CcSEcCtD
Propafenone—Malnutrition—Cisplatin—esophageal cancer	0.000534	0.00208	CcSEcCtD
Propafenone—Dysuria—Capecitabine—esophageal cancer	0.000528	0.00206	CcSEcCtD
Propafenone—Flatulence—Cisplatin—esophageal cancer	0.000526	0.00205	CcSEcCtD
Propafenone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000525	0.00205	CcSEcCtD
Propafenone—Weight increased—Capecitabine—esophageal cancer	0.000514	0.00201	CcSEcCtD
Propafenone—Muscle spasms—Cisplatin—esophageal cancer	0.000513	0.002	CcSEcCtD
Propafenone—Weight decreased—Capecitabine—esophageal cancer	0.000511	0.00199	CcSEcCtD
Propafenone—Hyperglycaemia—Capecitabine—esophageal cancer	0.000509	0.00199	CcSEcCtD
Propafenone—Infestation—Capecitabine—esophageal cancer	0.000504	0.00197	CcSEcCtD
Propafenone—Infestation NOS—Capecitabine—esophageal cancer	0.000504	0.00197	CcSEcCtD
Propafenone—Vision blurred—Cisplatin—esophageal cancer	0.000503	0.00196	CcSEcCtD
Propafenone—Depression—Capecitabine—esophageal cancer	0.000502	0.00196	CcSEcCtD
Propafenone—Tremor—Cisplatin—esophageal cancer	0.0005	0.00195	CcSEcCtD
Propafenone—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000496	0.00194	CcSEcCtD
Propafenone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000495	0.00193	CcSEcCtD
Propafenone—Renal failure—Capecitabine—esophageal cancer	0.000495	0.00193	CcSEcCtD
Propafenone—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000494	0.00193	CcSEcCtD
Propafenone—Anaemia—Cisplatin—esophageal cancer	0.000493	0.00193	CcSEcCtD
Propafenone—Jaundice—Capecitabine—esophageal cancer	0.000491	0.00192	CcSEcCtD
Propafenone—Stomatitis—Capecitabine—esophageal cancer	0.000491	0.00192	CcSEcCtD
Propafenone—Osteoarthritis—Methotrexate—esophageal cancer	0.000486	0.0019	CcSEcCtD
Propafenone—Malaise—Cisplatin—esophageal cancer	0.000481	0.00188	CcSEcCtD
Propafenone—Haematuria—Capecitabine—esophageal cancer	0.00048	0.00187	CcSEcCtD
Propafenone—Leukopenia—Cisplatin—esophageal cancer	0.000478	0.00187	CcSEcCtD
Propafenone—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000476	0.00186	CcSEcCtD
Propafenone—Epistaxis—Capecitabine—esophageal cancer	0.000475	0.00185	CcSEcCtD
Propafenone—Agranulocytosis—Capecitabine—esophageal cancer	0.00047	0.00183	CcSEcCtD
Propafenone—Convulsion—Cisplatin—esophageal cancer	0.000463	0.00181	CcSEcCtD
Propafenone—Bradycardia—Capecitabine—esophageal cancer	0.00046	0.0018	CcSEcCtD
Propafenone—Ataxia—Methotrexate—esophageal cancer	0.000457	0.00179	CcSEcCtD
Propafenone—Myalgia—Cisplatin—esophageal cancer	0.000454	0.00177	CcSEcCtD
Propafenone—Haemoglobin—Capecitabine—esophageal cancer	0.000454	0.00177	CcSEcCtD
Propafenone—Rhinitis—Capecitabine—esophageal cancer	0.000453	0.00177	CcSEcCtD
Propafenone—Anxiety—Cisplatin—esophageal cancer	0.000453	0.00177	CcSEcCtD
Propafenone—Hepatitis—Capecitabine—esophageal cancer	0.000452	0.00176	CcSEcCtD
Propafenone—Haemorrhage—Capecitabine—esophageal cancer	0.000452	0.00176	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000451	0.00176	CcSEcCtD
Propafenone—Hypoaesthesia—Capecitabine—esophageal cancer	0.00045	0.00176	CcSEcCtD
Propafenone—Liver function test abnormal—Methotrexate—esophageal cancer	0.000449	0.00175	CcSEcCtD
Propafenone—Discomfort—Cisplatin—esophageal cancer	0.000449	0.00175	CcSEcCtD
Propafenone—Urinary tract disorder—Capecitabine—esophageal cancer	0.000446	0.00174	CcSEcCtD
Propafenone—Connective tissue disorder—Capecitabine—esophageal cancer	0.000444	0.00173	CcSEcCtD
Propafenone—Urethral disorder—Capecitabine—esophageal cancer	0.000443	0.00173	CcSEcCtD
Propafenone—Breast disorder—Methotrexate—esophageal cancer	0.00044	0.00172	CcSEcCtD
Propafenone—Oedema—Cisplatin—esophageal cancer	0.000436	0.0017	CcSEcCtD
Propafenone—Visual impairment—Capecitabine—esophageal cancer	0.000436	0.0017	CcSEcCtD
Propafenone—Infection—Cisplatin—esophageal cancer	0.000433	0.00169	CcSEcCtD
Propafenone—Nervous system disorder—Cisplatin—esophageal cancer	0.000427	0.00167	CcSEcCtD
Propafenone—Thrombocytopenia—Cisplatin—esophageal cancer	0.000427	0.00167	CcSEcCtD
Propafenone—Tachycardia—Cisplatin—esophageal cancer	0.000425	0.00166	CcSEcCtD
Propafenone—Skin disorder—Cisplatin—esophageal cancer	0.000423	0.00165	CcSEcCtD
Propafenone—Eye disorder—Capecitabine—esophageal cancer	0.000422	0.00165	CcSEcCtD
Propafenone—Tinnitus—Capecitabine—esophageal cancer	0.000421	0.00165	CcSEcCtD
Propafenone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000421	0.00164	CcSEcCtD
Propafenone—Flushing—Capecitabine—esophageal cancer	0.00042	0.00164	CcSEcCtD
Propafenone—Cardiac disorder—Capecitabine—esophageal cancer	0.00042	0.00164	CcSEcCtD
Propafenone—Eosinophilia—Methotrexate—esophageal cancer	0.000416	0.00163	CcSEcCtD
Propafenone—Anorexia—Cisplatin—esophageal cancer	0.000415	0.00162	CcSEcCtD
Propafenone—Pancreatitis—Methotrexate—esophageal cancer	0.000412	0.00161	CcSEcCtD
Propafenone—Angiopathy—Capecitabine—esophageal cancer	0.00041	0.0016	CcSEcCtD
Propafenone—Immune system disorder—Capecitabine—esophageal cancer	0.000408	0.00159	CcSEcCtD
Propafenone—Mediastinal disorder—Capecitabine—esophageal cancer	0.000407	0.00159	CcSEcCtD
Propafenone—Hypotension—Cisplatin—esophageal cancer	0.000407	0.00159	CcSEcCtD
Propafenone—Arrhythmia—Capecitabine—esophageal cancer	0.000404	0.00158	CcSEcCtD
Propafenone—Alopecia—Capecitabine—esophageal cancer	0.000399	0.00156	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000397	0.00155	CcSEcCtD
Propafenone—Mental disorder—Capecitabine—esophageal cancer	0.000396	0.00155	CcSEcCtD
Propafenone—Malnutrition—Capecitabine—esophageal cancer	0.000394	0.00154	CcSEcCtD
Propafenone—Erythema—Capecitabine—esophageal cancer	0.000394	0.00154	CcSEcCtD
Propafenone—Dysuria—Methotrexate—esophageal cancer	0.000393	0.00153	CcSEcCtD
Propafenone—Paraesthesia—Cisplatin—esophageal cancer	0.000391	0.00153	CcSEcCtD
Propafenone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000391	0.00153	CcSEcCtD
Propafenone—Dyspnoea—Cisplatin—esophageal cancer	0.000388	0.00152	CcSEcCtD
Propafenone—Flatulence—Capecitabine—esophageal cancer	0.000388	0.00151	CcSEcCtD
Propafenone—Erectile dysfunction—Methotrexate—esophageal cancer	0.000387	0.00151	CcSEcCtD
Propafenone—Dysgeusia—Capecitabine—esophageal cancer	0.000385	0.0015	CcSEcCtD
Propafenone—Decreased appetite—Cisplatin—esophageal cancer	0.000379	0.00148	CcSEcCtD
Propafenone—Muscle spasms—Capecitabine—esophageal cancer	0.000378	0.00148	CcSEcCtD
Propafenone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000376	0.00147	CcSEcCtD
Propafenone—Infestation—Methotrexate—esophageal cancer	0.000375	0.00146	CcSEcCtD
Propafenone—Infestation NOS—Methotrexate—esophageal cancer	0.000375	0.00146	CcSEcCtD
Propafenone—Drowsiness—Methotrexate—esophageal cancer	0.000375	0.00146	CcSEcCtD
Propafenone—Depression—Methotrexate—esophageal cancer	0.000374	0.00146	CcSEcCtD
Propafenone—Pain—Cisplatin—esophageal cancer	0.000373	0.00145	CcSEcCtD
Propafenone—Vision blurred—Capecitabine—esophageal cancer	0.000371	0.00145	CcSEcCtD
Propafenone—Tremor—Capecitabine—esophageal cancer	0.000369	0.00144	CcSEcCtD
Propafenone—Renal failure—Methotrexate—esophageal cancer	0.000368	0.00144	CcSEcCtD
Propafenone—Stomatitis—Methotrexate—esophageal cancer	0.000365	0.00143	CcSEcCtD
Propafenone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000365	0.00143	CcSEcCtD
Propafenone—Anaemia—Capecitabine—esophageal cancer	0.000364	0.00142	CcSEcCtD
Propafenone—Feeling abnormal—Cisplatin—esophageal cancer	0.000359	0.0014	CcSEcCtD
Propafenone—Haematuria—Methotrexate—esophageal cancer	0.000357	0.0014	CcSEcCtD
Propafenone—Malaise—Capecitabine—esophageal cancer	0.000355	0.00139	CcSEcCtD
Propafenone—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000355	0.00138	CcSEcCtD
Propafenone—Epistaxis—Methotrexate—esophageal cancer	0.000354	0.00138	CcSEcCtD
Propafenone—Vertigo—Capecitabine—esophageal cancer	0.000354	0.00138	CcSEcCtD
Propafenone—Syncope—Capecitabine—esophageal cancer	0.000353	0.00138	CcSEcCtD
Propafenone—Leukopenia—Capecitabine—esophageal cancer	0.000352	0.00138	CcSEcCtD
Propafenone—Agranulocytosis—Methotrexate—esophageal cancer	0.00035	0.00137	CcSEcCtD
Propafenone—Palpitations—Capecitabine—esophageal cancer	0.000348	0.00136	CcSEcCtD
Propafenone—Loss of consciousness—Capecitabine—esophageal cancer	0.000346	0.00135	CcSEcCtD
Propafenone—Body temperature increased—Cisplatin—esophageal cancer	0.000344	0.00134	CcSEcCtD
Propafenone—Cough—Capecitabine—esophageal cancer	0.000343	0.00134	CcSEcCtD
Propafenone—Hypertension—Capecitabine—esophageal cancer	0.00034	0.00133	CcSEcCtD
Propafenone—Haemoglobin—Methotrexate—esophageal cancer	0.000338	0.00132	CcSEcCtD
Propafenone—Hepatitis—Methotrexate—esophageal cancer	0.000337	0.00131	CcSEcCtD
Propafenone—Haemorrhage—Methotrexate—esophageal cancer	0.000337	0.00131	CcSEcCtD
Propafenone—Chest pain—Capecitabine—esophageal cancer	0.000335	0.00131	CcSEcCtD
Propafenone—Myalgia—Capecitabine—esophageal cancer	0.000335	0.00131	CcSEcCtD
Propafenone—Anxiety—Capecitabine—esophageal cancer	0.000334	0.0013	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000333	0.0013	CcSEcCtD
Propafenone—Urinary tract disorder—Methotrexate—esophageal cancer	0.000332	0.0013	CcSEcCtD
Propafenone—Discomfort—Capecitabine—esophageal cancer	0.000331	0.00129	CcSEcCtD
Propafenone—Urethral disorder—Methotrexate—esophageal cancer	0.00033	0.00129	CcSEcCtD
Propafenone—Dry mouth—Capecitabine—esophageal cancer	0.000328	0.00128	CcSEcCtD
Propafenone—Visual impairment—Methotrexate—esophageal cancer	0.000324	0.00127	CcSEcCtD
Propafenone—Confusional state—Capecitabine—esophageal cancer	0.000324	0.00126	CcSEcCtD
Propafenone—Oedema—Capecitabine—esophageal cancer	0.000321	0.00125	CcSEcCtD
Propafenone—Hypersensitivity—Cisplatin—esophageal cancer	0.000321	0.00125	CcSEcCtD
Propafenone—Infection—Capecitabine—esophageal cancer	0.000319	0.00125	CcSEcCtD
Propafenone—Shock—Capecitabine—esophageal cancer	0.000316	0.00123	CcSEcCtD
Propafenone—Nervous system disorder—Capecitabine—esophageal cancer	0.000315	0.00123	CcSEcCtD
Propafenone—Eye disorder—Methotrexate—esophageal cancer	0.000314	0.00123	CcSEcCtD
Propafenone—Thrombocytopenia—Capecitabine—esophageal cancer	0.000314	0.00123	CcSEcCtD
Propafenone—Tinnitus—Methotrexate—esophageal cancer	0.000314	0.00122	CcSEcCtD
Propafenone—Tachycardia—Capecitabine—esophageal cancer	0.000313	0.00122	CcSEcCtD
Propafenone—Asthenia—Cisplatin—esophageal cancer	0.000313	0.00122	CcSEcCtD
Propafenone—Cardiac disorder—Methotrexate—esophageal cancer	0.000312	0.00122	CcSEcCtD
Propafenone—Skin disorder—Capecitabine—esophageal cancer	0.000312	0.00122	CcSEcCtD
Propafenone—Hyperhidrosis—Capecitabine—esophageal cancer	0.00031	0.00121	CcSEcCtD
Propafenone—Anorexia—Capecitabine—esophageal cancer	0.000306	0.0012	CcSEcCtD
Propafenone—Angiopathy—Methotrexate—esophageal cancer	0.000305	0.00119	CcSEcCtD
Propafenone—Immune system disorder—Methotrexate—esophageal cancer	0.000304	0.00119	CcSEcCtD
Propafenone—Mediastinal disorder—Methotrexate—esophageal cancer	0.000303	0.00118	CcSEcCtD
Propafenone—Hypotension—Capecitabine—esophageal cancer	0.0003	0.00117	CcSEcCtD
Propafenone—Diarrhoea—Cisplatin—esophageal cancer	0.000298	0.00116	CcSEcCtD
Propafenone—Alopecia—Methotrexate—esophageal cancer	0.000297	0.00116	CcSEcCtD
Propafenone—Mental disorder—Methotrexate—esophageal cancer	0.000295	0.00115	CcSEcCtD
Propafenone—Erythema—Methotrexate—esophageal cancer	0.000293	0.00114	CcSEcCtD
Propafenone—Malnutrition—Methotrexate—esophageal cancer	0.000293	0.00114	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000293	0.00114	CcSEcCtD
Propafenone—Insomnia—Capecitabine—esophageal cancer	0.00029	0.00113	CcSEcCtD
Propafenone—Paraesthesia—Capecitabine—esophageal cancer	0.000288	0.00113	CcSEcCtD
Propafenone—Dysgeusia—Methotrexate—esophageal cancer	0.000287	0.00112	CcSEcCtD
Propafenone—Dyspnoea—Capecitabine—esophageal cancer	0.000286	0.00112	CcSEcCtD
Propafenone—Carvedilol—ABCB1—esophageal cancer	0.000283	0.0351	CrCbGaD
Propafenone—Dyspepsia—Capecitabine—esophageal cancer	0.000283	0.0011	CcSEcCtD
Propafenone—Decreased appetite—Capecitabine—esophageal cancer	0.000279	0.00109	CcSEcCtD
Propafenone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000277	0.00108	CcSEcCtD
Propafenone—Vomiting—Cisplatin—esophageal cancer	0.000277	0.00108	CcSEcCtD
Propafenone—Fatigue—Capecitabine—esophageal cancer	0.000277	0.00108	CcSEcCtD
Propafenone—Vision blurred—Methotrexate—esophageal cancer	0.000276	0.00108	CcSEcCtD
Propafenone—Rash—Cisplatin—esophageal cancer	0.000275	0.00107	CcSEcCtD
Propafenone—Pain—Capecitabine—esophageal cancer	0.000275	0.00107	CcSEcCtD
Propafenone—Constipation—Capecitabine—esophageal cancer	0.000275	0.00107	CcSEcCtD
Propafenone—Dermatitis—Cisplatin—esophageal cancer	0.000274	0.00107	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000272	0.00106	CcSEcCtD
Propafenone—Anaemia—Methotrexate—esophageal cancer	0.000271	0.00106	CcSEcCtD
Propafenone—Feeling abnormal—Capecitabine—esophageal cancer	0.000265	0.00103	CcSEcCtD
Propafenone—Malaise—Methotrexate—esophageal cancer	0.000264	0.00103	CcSEcCtD
Propafenone—Vertigo—Methotrexate—esophageal cancer	0.000263	0.00103	CcSEcCtD
Propafenone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000263	0.00103	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—esophageal cancer	0.000262	0.00102	CcSEcCtD
Propafenone—Nausea—Cisplatin—esophageal cancer	0.000259	0.00101	CcSEcCtD
Propafenone—Fentanyl—ABCB1—esophageal cancer	0.000258	0.0319	CrCbGaD
Propafenone—Cough—Methotrexate—esophageal cancer	0.000256	0.000998	CcSEcCtD
Propafenone—Urticaria—Capecitabine—esophageal cancer	0.000255	0.000996	CcSEcCtD
Propafenone—Abdominal pain—Capecitabine—esophageal cancer	0.000254	0.000991	CcSEcCtD
Propafenone—Body temperature increased—Capecitabine—esophageal cancer	0.000254	0.000991	CcSEcCtD
Propafenone—Convulsion—Methotrexate—esophageal cancer	0.000254	0.000991	CcSEcCtD
Propafenone—Myalgia—Methotrexate—esophageal cancer	0.000249	0.000974	CcSEcCtD
Propafenone—Chest pain—Methotrexate—esophageal cancer	0.000249	0.000974	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000248	0.000967	CcSEcCtD
Propafenone—Discomfort—Methotrexate—esophageal cancer	0.000246	0.000962	CcSEcCtD
Propafenone—Confusional state—Methotrexate—esophageal cancer	0.000241	0.000941	CcSEcCtD
Propafenone—Infection—Methotrexate—esophageal cancer	0.000238	0.000927	CcSEcCtD
Propafenone—Hypersensitivity—Capecitabine—esophageal cancer	0.000237	0.000924	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—esophageal cancer	0.000234	0.000915	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—esophageal cancer	0.000234	0.000914	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—esophageal cancer	0.000232	0.000907	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000231	0.000902	CcSEcCtD
Propafenone—Asthenia—Capecitabine—esophageal cancer	0.00023	0.0009	CcSEcCtD
Propafenone—Anorexia—Methotrexate—esophageal cancer	0.000228	0.00089	CcSEcCtD
Propafenone—Pruritus—Capecitabine—esophageal cancer	0.000227	0.000887	CcSEcCtD
Propafenone—Hypotension—Methotrexate—esophageal cancer	0.000223	0.000872	CcSEcCtD
Propafenone—Diarrhoea—Capecitabine—esophageal cancer	0.00022	0.000858	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000218	0.00085	CcSEcCtD
Propafenone—Insomnia—Methotrexate—esophageal cancer	0.000216	0.000844	CcSEcCtD
Propafenone—Propranolol—ABCB1—esophageal cancer	0.000215	0.0267	CrCbGaD
Propafenone—Paraesthesia—Methotrexate—esophageal cancer	0.000215	0.000838	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—esophageal cancer	0.000213	0.000832	CcSEcCtD
Propafenone—Somnolence—Methotrexate—esophageal cancer	0.000213	0.00083	CcSEcCtD
Propafenone—Dizziness—Capecitabine—esophageal cancer	0.000212	0.000829	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—esophageal cancer	0.00021	0.000822	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—esophageal cancer	0.000208	0.000811	CcSEcCtD
Propafenone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000206	0.000806	CcSEcCtD
Propafenone—Fatigue—Methotrexate—esophageal cancer	0.000206	0.000805	CcSEcCtD
Propafenone—Pain—Methotrexate—esophageal cancer	0.000204	0.000798	CcSEcCtD
Propafenone—Vomiting—Capecitabine—esophageal cancer	0.000204	0.000797	CcSEcCtD
Propafenone—Rash—Capecitabine—esophageal cancer	0.000202	0.000791	CcSEcCtD
Propafenone—Dermatitis—Capecitabine—esophageal cancer	0.000202	0.00079	CcSEcCtD
Propafenone—Headache—Capecitabine—esophageal cancer	0.000201	0.000785	CcSEcCtD
Propafenone—Feeling abnormal—Methotrexate—esophageal cancer	0.000197	0.000769	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000196	0.000763	CcSEcCtD
Propafenone—Nausea—Capecitabine—esophageal cancer	0.000191	0.000745	CcSEcCtD
Propafenone—Urticaria—Methotrexate—esophageal cancer	0.00019	0.000741	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—esophageal cancer	0.000189	0.000738	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—esophageal cancer	0.000189	0.000738	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—esophageal cancer	0.000176	0.000688	CcSEcCtD
Propafenone—Asthenia—Methotrexate—esophageal cancer	0.000172	0.00067	CcSEcCtD
Propafenone—Pruritus—Methotrexate—esophageal cancer	0.000169	0.00066	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—esophageal cancer	0.000164	0.000639	CcSEcCtD
Propafenone—Dizziness—Methotrexate—esophageal cancer	0.000158	0.000617	CcSEcCtD
Propafenone—Vomiting—Methotrexate—esophageal cancer	0.000152	0.000593	CcSEcCtD
Propafenone—Rash—Methotrexate—esophageal cancer	0.000151	0.000589	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—esophageal cancer	0.000151	0.000588	CcSEcCtD
Propafenone—Headache—Methotrexate—esophageal cancer	0.00015	0.000585	CcSEcCtD
Propafenone—Nausea—Methotrexate—esophageal cancer	0.000142	0.000554	CcSEcCtD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	5.1e-05	0.000336	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA1—esophageal cancer	5.02e-05	0.000331	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC10A2—esophageal cancer	5.02e-05	0.000331	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.95e-05	0.000327	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.93e-05	0.000325	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PLCE1—esophageal cancer	4.9e-05	0.000323	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ADH7—esophageal cancer	4.9e-05	0.000323	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EGFR—esophageal cancer	4.86e-05	0.00032	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.84e-05	0.000319	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.84e-05	0.000319	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HIST1H2BM—esophageal cancer	4.8e-05	0.000317	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PDE4D—esophageal cancer	4.76e-05	0.000314	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	4.73e-05	0.000312	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA1—esophageal cancer	4.73e-05	0.000312	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BLVRB—esophageal cancer	4.71e-05	0.000311	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC52A3—esophageal cancer	4.71e-05	0.000311	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC10A2—esophageal cancer	4.69e-05	0.000309	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA1—esophageal cancer	4.69e-05	0.000309	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA2—esophageal cancer	4.59e-05	0.000303	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GNG7—esophageal cancer	4.53e-05	0.000299	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4.38e-05	0.000289	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA2—esophageal cancer	4.33e-05	0.000285	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ADH1B—esophageal cancer	4.3e-05	0.000283	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA2—esophageal cancer	4.29e-05	0.000283	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ADH7—esophageal cancer	4.27e-05	0.000281	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PLCE1—esophageal cancer	4.27e-05	0.000281	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—XIAP—esophageal cancer	4.24e-05	0.00028	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	4.23e-05	0.000279	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.21e-05	0.000278	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.19e-05	0.000276	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TYMP—esophageal cancer	4.11e-05	0.000271	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	4.03e-05	0.000266	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PLCE1—esophageal cancer	4.02e-05	0.000265	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ADH7—esophageal cancer	4.02e-05	0.000265	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CTNNA1—esophageal cancer	4.01e-05	0.000265	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA1—esophageal cancer	4.01e-05	0.000264	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC10A2—esophageal cancer	4.01e-05	0.000264	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	3.99e-05	0.000263	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL2—esophageal cancer	3.99e-05	0.000263	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ADH7—esophageal cancer	3.99e-05	0.000263	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.99e-05	0.000263	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.94e-05	0.00026	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALOX15—esophageal cancer	3.89e-05	0.000257	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ADH1B—esophageal cancer	3.74e-05	0.000247	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PSME2—esophageal cancer	3.73e-05	0.000246	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PSME1—esophageal cancer	3.73e-05	0.000246	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTO1—esophageal cancer	3.71e-05	0.000245	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TPI1—esophageal cancer	3.71e-05	0.000245	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ANXA1—esophageal cancer	3.71e-05	0.000244	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA2—esophageal cancer	3.67e-05	0.000242	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.66e-05	0.000241	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.64e-05	0.00024	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.64e-05	0.00024	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SST—esophageal cancer	3.61e-05	0.000238	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.58e-05	0.000236	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TYMP—esophageal cancer	3.58e-05	0.000236	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALDOB—esophageal cancer	3.56e-05	0.000235	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ADH1B—esophageal cancer	3.53e-05	0.000233	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH3—esophageal cancer	3.52e-05	0.000232	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GHRL—esophageal cancer	3.52e-05	0.000232	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.51e-05	0.000231	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ADH1B—esophageal cancer	3.5e-05	0.000231	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.48e-05	0.000229	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FBXW7—esophageal cancer	3.46e-05	0.000228	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.43e-05	0.000226	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GAPDH—esophageal cancer	3.43e-05	0.000226	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PLCE1—esophageal cancer	3.41e-05	0.000225	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADH7—esophageal cancer	3.41e-05	0.000225	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CRABP1—esophageal cancer	3.4e-05	0.000224	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALOX15—esophageal cancer	3.39e-05	0.000224	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TYMP—esophageal cancer	3.37e-05	0.000222	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.37e-05	0.000222	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TYMP—esophageal cancer	3.34e-05	0.00022	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	3.28e-05	0.000216	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP26A1—esophageal cancer	3.25e-05	0.000214	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TPI1—esophageal cancer	3.24e-05	0.000213	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTO1—esophageal cancer	3.24e-05	0.000213	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GNG7—esophageal cancer	3.23e-05	0.000213	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALOX15—esophageal cancer	3.2e-05	0.000211	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALOX15—esophageal cancer	3.17e-05	0.000209	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH2—esophageal cancer	3.15e-05	0.000208	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALDOB—esophageal cancer	3.1e-05	0.000205	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.09e-05	0.000204	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA1—esophageal cancer	3.09e-05	0.000204	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.05e-05	0.000201	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TPI1—esophageal cancer	3.05e-05	0.000201	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALDH2—esophageal cancer	3.03e-05	0.0002	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TPI1—esophageal cancer	3.02e-05	0.000199	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTO1—esophageal cancer	3.02e-05	0.000199	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.99e-05	0.000197	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GAPDH—esophageal cancer	2.99e-05	0.000197	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.98e-05	0.000197	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CRABP1—esophageal cancer	2.96e-05	0.000195	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.92e-05	0.000193	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.9e-05	0.000191	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.88e-05	0.00019	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.88e-05	0.00019	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TYMP—esophageal cancer	2.86e-05	0.000188	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.85e-05	0.000188	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.84e-05	0.000187	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA2—esophageal cancer	2.83e-05	0.000187	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GNG7—esophageal cancer	2.81e-05	0.000186	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.81e-05	0.000186	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFBR2—esophageal cancer	2.8e-05	0.000184	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.79e-05	0.000184	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.79e-05	0.000184	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.78e-05	0.000183	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.76e-05	0.000182	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.71e-05	0.000179	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ENO1—esophageal cancer	2.7e-05	0.000178	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.7e-05	0.000178	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PSME1—esophageal cancer	2.66e-05	0.000175	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PSME2—esophageal cancer	2.66e-05	0.000175	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GNG7—esophageal cancer	2.65e-05	0.000175	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SMAD4—esophageal cancer	2.65e-05	0.000175	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALDH2—esophageal cancer	2.64e-05	0.000174	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADH7—esophageal cancer	2.63e-05	0.000173	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.63e-05	0.000173	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GNG7—esophageal cancer	2.63e-05	0.000173	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TPI1—esophageal cancer	2.58e-05	0.00017	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.58e-05	0.00017	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTT1—esophageal cancer	2.51e-05	0.000165	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.49e-05	0.000164	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.48e-05	0.000164	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALDOB—esophageal cancer	2.48e-05	0.000163	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.46e-05	0.000162	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GAPDH—esophageal cancer	2.38e-05	0.000157	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTT1—esophageal cancer	2.36e-05	0.000156	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CRABP1—esophageal cancer	2.36e-05	0.000156	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS1—esophageal cancer	2.35e-05	0.000155	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ENO1—esophageal cancer	2.35e-05	0.000155	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.35e-05	0.000155	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTT1—esophageal cancer	2.34e-05	0.000155	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	2.34e-05	0.000154	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.32e-05	0.000153	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP2A6—esophageal cancer	2.32e-05	0.000153	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PSME2—esophageal cancer	2.32e-05	0.000153	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PSME1—esophageal cancer	2.32e-05	0.000153	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.31e-05	0.000152	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.31e-05	0.000152	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.29e-05	0.000151	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GNG7—esophageal cancer	2.25e-05	0.000148	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.22e-05	0.000146	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ENO1—esophageal cancer	2.22e-05	0.000146	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TYMP—esophageal cancer	2.2e-05	0.000145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ENO1—esophageal cancer	2.2e-05	0.000145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS1—esophageal cancer	2.2e-05	0.000145	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PSME1—esophageal cancer	2.18e-05	0.000144	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PSME2—esophageal cancer	2.18e-05	0.000144	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HIF1A—esophageal cancer	2.17e-05	0.000143	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PSME2—esophageal cancer	2.16e-05	0.000143	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PSME1—esophageal cancer	2.16e-05	0.000143	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	2.16e-05	0.000142	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.14e-05	0.000141	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.11e-05	0.000139	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.09e-05	0.000138	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KDR—esophageal cancer	2.07e-05	0.000137	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—esophageal cancer	2e-05	0.000132	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1B1—esophageal cancer	2e-05	0.000132	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TPI1—esophageal cancer	1.99e-05	0.000131	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.99e-05	0.000131	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.98e-05	0.000131	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.97e-05	0.00013	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.97e-05	0.00013	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH1—esophageal cancer	1.95e-05	0.000129	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.93e-05	0.000127	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.91e-05	0.000126	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.89e-05	0.000125	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.89e-05	0.000125	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.88e-05	0.000124	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.88e-05	0.000124	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO1—esophageal cancer	1.88e-05	0.000124	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.88e-05	0.000124	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.87e-05	0.000123	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSME1—esophageal cancer	1.85e-05	0.000122	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSME2—esophageal cancer	1.85e-05	0.000122	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.84e-05	0.000121	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.82e-05	0.00012	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.77e-05	0.000117	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CREBBP—esophageal cancer	1.77e-05	0.000117	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.76e-05	0.000116	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—esophageal cancer	1.74e-05	0.000115	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GNG7—esophageal cancer	1.73e-05	0.000114	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—esophageal cancer	1.71e-05	0.000113	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.66e-05	0.00011	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.62e-05	0.000107	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.62e-05	0.000107	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.61e-05	0.000106	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.6e-05	0.000106	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.6e-05	0.000105	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—esophageal cancer	1.58e-05	0.000104	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.57e-05	0.000104	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.55e-05	0.000102	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.55e-05	0.000102	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.54e-05	0.000101	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.53e-05	0.000101	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—esophageal cancer	1.51e-05	9.95e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.5e-05	9.89e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB2—esophageal cancer	1.48e-05	9.77e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO1—esophageal cancer	1.45e-05	9.55e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.45e-05	9.55e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.43e-05	9.42e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSME1—esophageal cancer	1.43e-05	9.41e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSME2—esophageal cancer	1.43e-05	9.41e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.37e-05	9.03e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.34e-05	8.86e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.31e-05	8.66e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—esophageal cancer	1.31e-05	8.63e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1A—esophageal cancer	1.27e-05	8.35e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.26e-05	8.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.23e-05	8.12e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EP300—esophageal cancer	1.21e-05	7.95e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.16e-05	7.67e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.16e-05	7.63e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—esophageal cancer	1.13e-05	7.45e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CREBBP—esophageal cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.06e-05	6.97e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—esophageal cancer	1.05e-05	6.92e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.04e-05	6.84e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.03e-05	6.82e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.03e-05	6.78e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—esophageal cancer	1.03e-05	6.77e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.01e-05	6.69e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.93e-06	6.55e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—esophageal cancer	9.85e-06	6.49e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—esophageal cancer	9.28e-06	6.12e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—esophageal cancer	9.2e-06	6.07e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—esophageal cancer	9.01e-06	5.94e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—esophageal cancer	8.91e-06	5.88e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CREBBP—esophageal cancer	8.78e-06	5.79e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—esophageal cancer	8.62e-06	5.69e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—EP300—esophageal cancer	8.6e-06	5.67e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—esophageal cancer	8.49e-06	5.6e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—esophageal cancer	8.42e-06	5.55e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—esophageal cancer	7.86e-06	5.18e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—EP300—esophageal cancer	7.49e-06	4.94e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—esophageal cancer	7.19e-06	4.74e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—EP300—esophageal cancer	7.06e-06	4.66e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—EP300—esophageal cancer	7e-06	4.62e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.78e-06	4.47e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	6.36e-06	4.19e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—esophageal cancer	6.07e-06	4e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—EP300—esophageal cancer	5.98e-06	3.94e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.55e-06	3.66e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.54e-06	3.65e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	5.22e-06	3.44e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—esophageal cancer	5.18e-06	3.41e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—EP300—esophageal cancer	4.62e-06	3.04e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—esophageal cancer	4.42e-06	2.92e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.41e-06	2.25e-05	CbGpPWpGaD
